Skip to content

Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study

Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study/ 18F-AV-45-A14 - CLINICAL EVALUATION OF FLORBETAPIR F 18 (18F-AV-45) Sponsor of 18F-AV-45-A14: Avid Radiopharmaceuticals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01834716
Enrollment
16
Registered
2013-04-18
Start date
2013-04-30
Completion date
2014-12-31
Last updated
2019-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease Prevention

Brief summary

Researchers are trying to determine if cognitively normal subjects undergoing a moderate aerobic exercise program will accumulate less amyloid-ß (Aβ) concentration in their brain than subjects undergoing a non-aerobic exercise program, and further evaluating the safety and imaging characteristics of florbetapir F 18, the radioactive drug that will allow us to image changes in the brain amyloid-ß (Aβ).

Detailed description

After screening assessments have been completed, subjects will be randomized into one of two groups: aerobic exercise group and non-aerobic exercise group. All subjects will be trained on the Physical Activity Scale for the Elderly (PASE), using the Body Media armband, and exercise diary. Subjects will also complete an online food questionnaire. Subjects assigned to the aerobic exercise group will work with an exercise trainer who will provide individual training (six half hour sessions) until they are proficient at the use of the equipment and understand goals. Subjects will return to Brooks Family YMCA at their convenience, but at a minimum of four times per week. Subjects will complete the exercise journal daily and the Physical Activity Scale for the Elderly (PASE) questionnaire on a monthly basis. Subjects assigned to the non-aerobic exercise group will attend supervised classes on toning and stretching at a minimum of four times per week. Subjects will complete the exercise journal daily and the Physical Activity Scale for the Elderly (PASE) questionnaire on a monthly basis.

Interventions

BEHAVIORALAerobic vs. Non-Aerobic exercise

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 65 years of age or older. * Not diagnosed with memory problems. * Do not exercise in which you sweat and/or raise your pulse rate more than 30 minutes two times per week. * Able to walk ten blocks (about one mile). * Willing to participate in weekly exercise classes at the Brooks YMCA for six months. * Able to have an MRI and CT/PET scan.

Design outcomes

Primary

MeasureTime frameDescription
Number of Subjects Retained at 6 Months6 monthsThe number of subjects retained at 6 month end of study time point.

Countries

United States

Participant flow

Recruitment details

Participants were recruited via study invitations mailed to persons by age and zip code. Local community presentations were also conducted to recruit subjects.

Participants by arm

ArmCount
Non-aerobics Exercise
Participants in this group will be randomized to a non-aerobics exercise group (attending classes of toning and stretching a minimum of three times per week).
4
Aerobics Exercise
Participants in this group will be randomized to an aerobics exercise group (the equivalent of walking briskly for 50 minutes three times per week).
12
Total16

Baseline characteristics

CharacteristicNon-aerobics ExerciseAerobics ExerciseTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants12 Participants16 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Region of Enrollment
United States
4 participants12 participants16 participants
Sex: Female, Male
Female
3 Participants4 Participants7 Participants
Sex: Female, Male
Male
1 Participants8 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 4
other
Total, other adverse events
0 / 120 / 4
serious
Total, serious adverse events
1 / 120 / 4

Outcome results

Primary

Number of Subjects Retained at 6 Months

The number of subjects retained at 6 month end of study time point.

Time frame: 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Aerobics ExerciseNumber of Subjects Retained at 6 Months11 Participants
Non-Aerobics ExerciseNumber of Subjects Retained at 6 Months4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026